Sutro Biopharma reported $62 million in 2024 revenue, down from $153.7 million in 2023, and announced a pipeline restructuring.

We recently compiled a list of the 10 Best Stocks Under $3 to Buy Now. In this article, we are going to take a look at where ...

We recently published a list of 12 Best Multibagger Stocks to Buy in 2025. In this article, we are going to take a look at ...

As the European markets navigate the complexities of U.S. trade policy uncertainties, recent economic measures by Germany and the European Union have provided some stability amidst volatility. Penny ...

Global markets have recently been impacted by tariff fears, inflation concerns, and growth uncertainties, leading to a decline in major U.S. stock indexes. Despite these challenges, the search for ...

Arizona State Retirement System boosted its position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 2.4% in the 4th quarter, according to its most recent filing with the Securities ...

Investment analysts at Wedbush boosted their FY2025 earnings estimates for shares of Fennec Pharmaceuticals in a research ...